Diabesity: an old term, a modern challenge - multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes. [PDF]
Hoffmann K +18 more
europepmc +1 more source
The locus coeruleus calcitonin receptor can Be engaged by amylin and calcitonin gene-related peptide to suppress feeding without inducing nausea. [PDF]
Fortin SM +8 more
europepmc +1 more source
From pathophysiology to therapy: dual and triple agonists as a new frontier in metabolic dysfunction-associated steatotic liver disease. [PDF]
Argano C +9 more
europepmc +1 more source
Effect of GLP-1 receptor agonist on nutrient intake: A narrative review. [PDF]
Fujioka K.
europepmc +1 more source
Precision Pharmacotherapy for Childhood Obesity: Molecular Targets Beyond Single GLP-1 Receptor Agonism and a Framework for Disease Modification. [PDF]
Dauleh H, Hussain K.
europepmc +1 more source
Incretin-Based Therapies as Cardiometabolic Interventions: Outcome Hierarchy, Receptor-Network Pharmacology and Phenotype-Based Clinical Positioning. [PDF]
Sztanek F +3 more
europepmc +1 more source
Molecularly guided pharmacotherapy for obesity: emerging targets, clinical efficacy, and personalized therapeutic approaches. [PDF]
Mao J, Hu R.
europepmc +1 more source
New Amylin-Based Agonists for the Treatment of Obesity and Type 2 Diabetes Mellitus. [PDF]
Panou T +3 more
europepmc +1 more source
Peptide Marriages: Modular Assembly of Multi-Agonist Therapeutics. [PDF]
Kostadinova KA +11 more
europepmc +1 more source
The evolving therapeutic landscape of gut-pancreatic peptide signalling in metabolic disorders: from mono- to multi-agonist therapies. [PDF]
Patil M +4 more
europepmc +1 more source

